Levodropropizine

• CAT Number: A000473
• CAS Number: 99291-25-5
• Molecular Formula: C13H20N2O2
• Molecular Weight: 236.31
• Purity: ≥95%
• Target: Neuronal Signaling
• Solubility: Soluble in DMSO > 10 mM
• Storage: 3 years -20C powder
• IUPAC Name: (2S)-3-(4-phenylpiperazin-1-yl)propane-1,2-diol
• InChI: InChI=1S/C13H20N2O2/c16-11-13(17)10-14-6-8-15(9-7-14)12-4-2-1-3-5-12/h1-5,13,16-17H,6-11H2/t13-/m0/s1
• InChIKey: PTVWPYVOOKLBCG-ZDUSSCGKSA-N
• SMILES: C1CN(CCN1C[C@@H](CO)O)C2=CC=CC=C2

Levodropropizine（Cat No.:A000473）is a non-narcotic antitussive agent primarily used to treat dry, non-productive cough. It works by inhibiting peripheral sensory nerves in the respiratory tract, reducing cough reflex sensitivity without acting on the central nervous system. Unlike opioid-based cough suppressants, Levodropropizine has minimal sedative effects and a lower risk of dependence, making it a safer option for both adults and children. It is commonly prescribed for conditions like bronchitis, tracheitis, and laryngitis, providing effective cough relief while maintaining a favorable safety and tolerability profile.